AstraZeneca receives EU approval for lung cancer drug Tagrisso
Tagrisso reduced the risk of disease recurrence or death by 80% in the overall trial population of patients
Company
AstraZeneca PLC
LON:AZN
AstraZeneca is one of the world's leading pharmaceutical companies, with a broad range of medicines designed to fight disease. AstraZeneca has over 67,000 empolyees and operates in over 100 countries with growing presence in important emerging markets.
1076 stories · page 5 of 11
Archive
Arrow Global and Informa next in the firing line on executive pay after AstraZeneca furore
Après Soriot, le déluge? Institutional investors have been cutting up rough more than usual this year over executive pay, although they have yet to win a significant victory.
German scientists claim to know why AstraZeneca, Johnson & Johnson COVID-19 vaccines cause blood clots
The DNA-based formulations that have been linked to very rare cases of blood clots, some of which caused death
AstraZeneca prices £691mln bond offering linked to Alexion Pharmaceuticalsacquisition
The notes must be redeemed before the maturity date if the deal doesn’t happen before March 2022 or if it gets scrapped
AstraZeneca's £27.5bn acquisition of Alexion under investigation by competition watchdog
The CMA has opened an invitation to comment until 3 June for parties involved
Coronavirus vaccines: UK hits 60mln doses milestone as new study proves AstraZeneca, Pfizer/BioNTech jabs work against Indian variant
Two doses are required to get strong protection against the new strain
Archive
AstraZeneca and Moderna receive approval for COVID-19 vaccines in Japan
The Vaxzevria jab will be administered in two doses given four to 12 weeks apart
AstraZeneca vaccine up to 90% effective 'real-life data' indicates
Government has said that it is confident the vaccines are effective against the Indian variant.
Heated AGM season is underway as shareholders fight pay hikes for bosses
AstraZeneca, Rio Tinto and Glencore are part of a long list of companies that are facing backlash over remuneration packages
Big chunk of AstraZeneca shareholders vote against boss pay hike but majority still backs it
The pay proposal includes bonuses of £12mln or more
AstraZeneca faces investor backlash after hiking chief executive bonus by £2.3mln
Aviva and Standard Life Aberdeen have voted to block the proposal ahead of Tuesday’s AGM
AstraZeneca posts positive final-stage trial results for lung cancer treatment
The candidate was analysed in combination with platinum-based chemotherapy, or antibody tremelimumab and chemotherapy, compared to chemotherapy alone
Archive
Today's Market View - AfriTin; Arc Minerals; Kodal Minerals; Mkango Resources and more...
UK – Strong manufacturing PMI data released this morning with growth in production and new orders among the strongest in the past seven years leading to a solid increase in employment. Further loosening of COVID-19 restrictions at home and
AstraZeneca shares have decoupled from vaccine headlines, says Barclays
The pharma giant is “becoming a cleaner story for investors to own”, analysts said
AstraZeneca receives US approval for chronic kidney disease drug
The firm said it is the most significant advancement in the treatment of chronic kidney disease in more than 20 years
AstraZeneca boss defends Covid-19 vaccine supply, "doing best it can"
AstraZeneca was in court defending itself this week after the EU launched legal action
AstraZeneca bullish on outlook as no-profit COVID-19 vaccine delivers US$275mln quarterly sales
The pharma giant said the second half will see a boost in performance
Archive
FTSE 100 closes on the front foot, with AstraZeneca the top riser
Footsie finished Friday ahead by around eight points, or 0.12%, at 6,969,
Archive
AstraZeneca to show there is more to the company than the COVID-19 vaccine
FTSE 100 giants AstraZeneca and Barclays are set to declare first-quarter results on Friday
Coronavirus: One vaccine dose enough to cut transmission risk by half, AstraZeneca/EU legal challenge begins
The EU Commission has sued the pharma giant over COVID-19 vaccine deliveries
AstraZeneca COVID-19 jab developer Vaccitech sets IPO price
The offer will consist of 6.5mln American Depositary Shares (ADS) priced at US$16-18 each
AstraZeneca sued by EU Commission over COVID-19 vaccine deliveries
All 27 states backed the legal challenge, which started last Friday
Coronavirus: Netherlands won’t use millions AstraZeneca vaccine doses, Valneva seeks 4,000 UK volunteers for jab trials
A Dutch official said the doses will be left behind once the country receives supplies from other manufacturers
AstraZeneca posts trio of good news, including two EU approval recommendations for cancer drugs
An EMA committee recommended conditional marketing authorisation for both selumetinib and tagrisso
COVID-19 infections fall significantly after single dose vaccines are rolled out, study shows
The first dose of a COVID-19 vaccine was enough to push infections down by 65%
Archive
Today's Market View - Anglo American; Arkle Resources; Centamin and more...
Gold - $1,793/oz – prices break out as Bitcoin melts down and on prospects for further stimulus funding in India and other emerging markets Rise in Indian Covid cases creates new concern for central bankers and policymakers as Delhi locksdo
AstraZeneca faces legal challenge by EU over COVID-19 vaccine deliveries
The pharma giant should tread carefully, analysts said, as the EU is a vital part of its business
AstraZeneca receives green light from US regulators for Alexion acquisition
The pharma firm agreed to acquire the rare disease specialist in December last year in a deal worth US$39bn
Risk of rare blood clots higher for COVID-19 than for vaccines, research shows
Cases were more common after COVID-19 than in any of the comparison groups, with 30% of these cases occurring in the under 30s
Coronavirus: Oxford University expands ‘mix and match’ vaccine trial, South African variant in London concerns scientists over lockdown easing
Mixing vaccines could allow for a more flexible rollout and to make up for shortfalls of doses, researchers said
AstraZeneca, Johnson & Johnson COVID-19 vaccine contracts not expected to be renewed by EU
The bloc is planning to focus on mRNA-based vaccines, such as those produced by Pfizer and Moderna
AstraZeneca wins approval in China for early-stage lung cancer treatment Tagrisso
More than a third of the world's lung cancer patients are in China
AstraZeneca reports disappointing final stage trials of diabetes drug in COVID-19 treatment
The primary goals were prevention of organ dysfunction and death as well as recovery over 30 days
UK has enough COVID-19 vaccines for under 30s after decision on AstraZeneca jab, says minister
Also, a new study suggests there is a correlation between the fall in deaths and the vaccine rollout in the UK
Are AstraZeneca shares still a 'buy'? These two heavyweight banks think so
Both UBS and Citi restated their guidance on the stock
AstraZeneca COVID-19 jab developer Vaccitech prepares for £509mln New York IPO
One of the co-founders is Sarah Gilbert, the University of Oxford professor behind the vaccine
AstraZeneca vaccine should not be offered to healthy under 30s, UK government says
The authorities stressed that the jab's benefits continue to outweigh the risks
AstraZeneca COVID-19 vaccine fine for use, says EU regulator
The benefits in preventing the disease outweigh risks of side effects, the EMA said
Moderna vaccine introduced weeks early as verdict on AstraZeneca jab awaited
The shot is expected to be used in the rest of the United Kingdom by the middle of April.
Valneva gives UK vaccine progamme another boost with strong trial result
Valneva's vaccine VLA2001 also sparked broad T-cell responses
AstraZeneca vaccine might be restricted to over-30s due to blood clot concern
“No decision has yet been made on any regulatory action.”
Archive
FTSE 100 ends higher on lockdown easing hopes; Wall Street mixed after initial false start
The UK blue chip index remained buoyant but Wall Street sees some profit taking after this week's new records
Archive
Today's Market View - Condor Gold; Conroy Gold & Natural Resources; IronRidge Resources; Vast Resources and more...
Condor Gold* (AIM:CNR) 47.5p, Mkt Cap £62.0m – Progress of infill drilling at La India Condor Gold reports that it has now completed the first 40 holes (2,170m) of its closely spaced infill drilling programme within the area of the starter
UK to share COVID-19 surplus vaccines abroad after all adults vaccinated
Business minister Kwasi Kwarteng said the “focus has to be to try and keep Britain safe” as over 30mln people have received a jab
AstraZeneca urged to catch up with COVID-19 vaccine deliveries by EU chief
Meanwhile, the University of Oxford is launching a study to deliver the vaccine via a nasal spray instead of injecting it
AstraZeneca publishes primary COVID-19 vaccine trial results consistent with Monday data
The primary analysis will be the basis for a regulatory submission for Emergency Use Authorization in the US
Archive
Today's Market View - Altus Strategies; Oriole Resources and more...
Altus Strategies* (AIM:ALS) - BUY – Drilling intersects potential new parallel gold zone at Tabakorole Oriole Resources (LON:ORR) – Senala exploration plan Rio Tinto (LON:RIO) – Rio Tinto’s plan to strengthen “Cultural Heritage management”
US agency asks AstraZeneca to review COVID-19 vaccine trial results
It is understood that AstraZeneca may have included outdated information from that trial, which may have provided an incomplete view of the efficacy data
Coronavirus: Boris Johnson to lobby EU leaders to halt AstraZeneca vaccine export ban
The Commission is looking to prevent jabs made on the continent to be delivered abroad because AstraZeneca is not meeting contractual obligations
AstraZeneca says COVID-19 vaccine shows 100% efficacy against severe disease, hospitalisation with no safety concerns
An independent committee found no increased risk of thrombosis in late-stage trials of over 32,000 people
AstraZeneca to hear from EU regulator on COVID-19 vaccine today
Experts from the European Medicines Agency are discussing whether to keep rolling out the jab in the bloc
AstraZeneca upgraded to ‘buy’ by Jefferies as pipeline should aid recovery of shares
The US investment bank reckons the risk-reward is significantly more positive
AstraZeneca COVID-19 vaccine to be reviewed by WHO, EU regulator
The European Medicines Agency will issue a decision on Thursday
AstraZeneca extends US agreement for COVID-19 treatment candidate
The total value of the contracts with US governments concerning the AZD7442 candidate is US$726mln
Archive
FTSE 100 closes firmly ahead as traders await Central bank comment; Astrazeneca shares rise
The European Medicines Agency has said it has not found any evidence of causality; correlation is not causation, as the old adage has it.
AstraZeneca defends Coronavirus vaccine after new suspensions in Netherlands, Republic of Ireland
Several EU countries and Thailand have put the jab rollout on hold over concerns of blood clots reports in Norway
AstraZeneca vaccine suspended in Denmark over side effect concerns
On Monday, Austria suspended vaccinations after a 49-year old nurse died from severe blood clots.
AstraZeneca says US court rules in its favour for Symbicort litigation
The pharma giant has been in litigation against Mylan and Kindeva
AstraZeneca reportedly cashes in US$1.2bn after selling Moderna, Inc. stake
Shares in Moderna have rocketed over 400% since a year ago after it successfully developed a COVID-19 jab
AstraZeneca withdraws bladder cancer drug in US
The withdrawal is in line with guidance on accelerated approvals that did not meet post-marketing requirements
Coronavirus: AstraZeneca to prepare jabs against new variants by autumn
The firm is testing modified versions of the current vaccine with clinical trials earmarked for the spring
AstraZeneca expects low teens percentage full-year revenue growth excluding COVID-19 vaccine
Sales have been rising thanks to new medicines, with plans to further invest in research and development
Archive
FTSE 100 closes slightly ahead as Brexit and virus fears weigh on sentiment
Britain's blue-chip benchmark finished the day up around four points at 6,528
AstraZeneca and Royal Mail in the spotlight on Thursday
AstraZeneca and Royal Mail are among the notable names in Thursday's diary.
South Africa stops use of AstraZeneca vaccine due to new variant worries
The AstraZeneca vaccine and the alternative developed by Pfizer/BioNTech both work very well against the original form of Covid-19.
UK Government teams up with CureVac to find mutant COVID-19 vaccine
Earlier this week, Curevac announced it had agreed a €150mln joint venture with GlaxoSmithKline to develop mRNA-based vaccines
AstraZeneca says Imfinzi misses target in final stage head and neck cancer trial
Insights from the KESTREL Phase III trial will advance our understanding and application of immunotherapy, the FTSE 100 company said
Coronavirus: UK starts vaccine trials mixing AstraZeneca doses with Pfizer/BioNTech jab
Participants will receive different COVID-19 vaccines for their first or second dose
AstraZeneca gets heart failure treatment approved in China
The therapy can be used in adults with heart failure with problems to the left ventricle and without type-2 diabetes
Coronavirus: Russian vaccine Sputnik V shows 91.6% efficacy rate
The jab was safe and offered complete protection against hospitalisation and death
Coronavirus: UK launches surge testing to detect South African variant, vaccines less effective against it
This weel AstraZeneca is expected to release tests on its vaccine against the new strain, with most competitors reporting lower efficacy rates
Coronavirus: Ryanair says EU needs to speed up vaccine rollout, AstraZeneca to deliver extra 9mln vaccine doses to EU
The row between the pharma giant and the bloc has culminated in a promise for more supplies, while the UK is on track to meet its mid-February vaccination target
Coronavirus: EU approves AstraZeneca PLC vaccine for all over-18s, Novavax jab shown to be 89% effective
The approval will come hours after the EU published the contract signed with the pharma giant to back up its requests
Coronavirus: Row between AstraZeneca and EU continues as Germany advises against use on over 65s for lack of efficacy data
Meanwhile, French firm Valneva has begun large-scale vaccine manufacturing in Scotland
AstraZeneca confident UK can hit Covid-19 target as Sanofi agrees to make vaccine for Pfizer
UK deaths attributed to virus rose to more than 100,000 yesterday
Coronavirus: AstraZeneca defends against vaccine allegations amid EU tit-for-tat over Pfizer jab
AstraZeneca can only deliver half of the doses promised for the first quarter but officials said the explanations were insufficient
AstraZeneca says China approves mild asthma reliever
Symbicort Turbuhaler was already approved in the Asian country for patients with moderate to severe symptoms
AstraZeneca receives approval in Japan for leukaemia drug
The same candidate, Calquence, also met its main goal in another trial on blood cancer patients
Pfizer/BioNTech coronavirus vaccine effective against UK variant suggests study
The co-founders of BioNTech were involved in the study
AstraZeneca says EU approves breast cancer drug
Over half a million women in Europe are diagnosed with the disease annually
Coronavirus: UK vaccine supply hindered by manufacturing issues, London to pilot 24/7 inoculation sites…
The latest news on the UK's COVID-19 vaccination programme
AstraZeneca receives US approval for stomach cancer drug
Enhertu can be now used to treat adults with locally advanced or metastatic tumours that have higher than normal levels of a protein called HER2
AstraZeneca says EU, UK approve cancer drug for additional dosing option
This new dosing option is consistent with the approved Imfinzi dosing in another type of tumour
Coronavirus: High street pharmacies start vaccine rollout as Boris Johnson promises 24/7 injections
In today's coronavirus news, updates on the vaccine programme in the UK and results from a study on former patients
Coronavirus: UK progresses with vaccine rollout, Bayer partners with CureVac, US monitors allergic reactions
There were various major developments regarding COVID-19 vaccines on Thursday
Coronavirus: UK may face tougher restrictions as Boris Johnson to address nation on Monday night
Meanwhile, Scotland is entering lockdown on Monday at midnight
Coronavirus: UK starts rollout of AstraZeneca/Oxford vaccine
The FTSE 100 firm has provided 530,000 doses ready for use on Monday at six hospital trusts
AstraZeneca completes sale of heart failure treatment commercial rights for US$400mln
The buyer is German pharma company Cheplapharm, which paid US$250mln on completion of the deal and will pay the balance in the first half of 2021
Archive
FTSE 100 closes the year 15% below January levels under coronavirus, Brexit pressure
The FTSE 100 index closed out the last session of this benighted year 95.30 points lower at 6,460.52, a level last seen in July 2016
Millions in UK placed in Tier-4 as mutant COVID-19 strain spreads
Hancock said that recent surge in infections had made tougher restrictions necessary across the country.
AstraZeneca and Oxford University COVID-19 vaccine given UK go-ahead
People aged 18 or over will receive two shots of the vaccine with the second dose administered 4-12 weeks after the first.
Archive
FTSE 100 closes lower on final full-day session of annus horribilis 2020
The UK blue-chip index closed down 46.83 points, or 0.7% at 6,555.82, only just above the session low of 6,552.466, and well below the early peak of 6,622.98
AstraZeneca shares rise as University of Oxford vaccine poised for UK approval
A new study has indicated that 2mln people a week in the UK would need to be vaccinated to avoid a third wave of the coronavirus outbreak
Archive
FTSE 100 sees solid post-Christmas gain, but closes off highs as US blue-chips see profit-taking
At the close, the UK blue-chip index was up 100.54 points, or 1.6% at 6,602.65, albeit well below the session peak of 6,676.60
AstraZeneca/Oxford vaccine might be approved within days
“I would expect some news pretty shortly, I doubt we will make Christmas now but just after Christmas I would expect.”
AstraZeneca lung cancer drug receives US regulatory green light
Tagrisso will be used to target the early-stage epidermal growth factor receptor-mutated form of the disease
What's behind AstraZeneca's US$39bn deal for Alexion Pharmaceuticals?
The deal comes six and a half years after the advances of Pfizer were rejected, nixing what would have been the biggest ever takeover of a UK company by a foreign rival
AstraZeneca swoops with US$39bn bid for rare disease specialist Alexion
The acquisition is expected to close in the third quarter of 2021 and produce around US$500mln of savings in three years as well as strengthening cash-flow generation
AstraZeneca to test vaccine combo with Russia's Sputnik as Glaxo's effort falters
Russian scientists have claimed that as the two are both common-cold based treatments combining them would greatly enhance the Astra vaccine,
People with severe allergies told to avoid Pfizer/BioNTech vaccine after two NHS workers have reaction
Chris Whitty says vaccine will greatly reduce hospital admissions